Incannex Healthcare Files 8-K with Press Release
Ticker: IXHL · Form: 8-K · Filed: Mar 27, 2026 · CIK: 0001873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, filing, press-release
TL;DR
INCANNEX FILES 8-K - PRESS RELEASE OUT MARCH 27TH
AI Summary
Incannex Healthcare Inc. filed an 8-K on March 27, 2026, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The filing includes a press release dated March 27, 2026, and associated graphic files, along with XBRL data.
Why It Matters
This filing provides important updates and disclosures from Incannex Healthcare Inc. to the public, ensuring transparency regarding company information.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for disclosure purposes and does not indicate any immediate financial or operational risks.
Key Players & Entities
- Incannex Healthcare Inc. (company) — Filer of the 8-K
- 0001873875 (company) — CIK number for Incannex Healthcare Inc.
- 2026-03-27 (date) — Filing date and period of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits, including a press release dated March 27, 2026.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on March 27, 2026, at 08:00:23.
What types of documents are included in this filing?
The filing includes a current report (8-K), a press release dated March 27, 2026, graphic files, and XBRL data files.
What is the CIK number for Incannex Healthcare Inc.?
The CIK number for Incannex Healthcare Inc. is 0001873875.
What is the business address of Incannex Healthcare Inc.?
The business address of Incannex Healthcare Inc. is 8 CENTURY CIRCUIT STE. 105 NORWEST NSW NSW Australia.
Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2026-03-27 08:00:23
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
Filing Documents
- ea0283742-8k_incannex.htm (8-K) — 26KB
- ea028374201ex99-1.htm (EX-99.1) — 13KB
- ea028374201_ex99-1img1.jpg (GRAPHIC) — 16KB
- 0001213900-26-035161.txt ( ) — 229KB
- ixhl-20260327.xsd (EX-101.SCH) — 3KB
- ixhl-20260327_lab.xml (EX-101.LAB) — 33KB
- ixhl-20260327_pre.xml (EX-101.PRE) — 22KB
- ea0283742-8k_incannex_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated as of March 27, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: March 27, 2026 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 2